4.5 Article

Limitations of Time-Resolved Fluorescence Suggested by Molecular Simulations: Assessing the Dynamics of T cell Receptor Binding Loops

期刊

BIOPHYSICAL JOURNAL
卷 103, 期 12, 页码 2532-2540

出版社

CELL PRESS
DOI: 10.1016/j.bpj.2012.10.037

关键词

-

资金

  1. National Institute of General Medical Services (NIGMS), National Institutes of Health (NIH) [GM067079, GM075762]
  2. National Science Foundation (NSF) [MCB-0448298, CHE-0845736]
  3. Division Of Chemistry
  4. Direct For Mathematical & Physical Scien [0845736] Funding Source: National Science Foundation

向作者/读者索取更多资源

Time-resolved fluorescence anisotropy (TRFA) has a rich history in evaluating protein dynamics. Yet as often employed, TRFA assumes that the motional properties of a covalently tethered fluorescent probe accurately portray the motional properties of the protein backbone at the probe attachment site. In an extensive survey using TRFA to study the dynamics of the binding loops of a alpha beta T cell receptor, we observed multiple discrepancies between the TRFA data and previously published results that led us to question this assumption. We thus simulated several of the experimentally probed systems using a protocol that permitted accurate determination of probe and protein time correlation functions. We found excellent agreement in the decays of the experimental and simulated correlation functions. However, the motional properties of the probe were poorly correlated with those of the backbone of both the labeled and unlabeled protein. Our results warrant caution in the interpretation of TRFA data and suggest further studies to ascertain the extent to which probe dynamics reflect those of the protein backbone. Meanwhile, the agreement between experiment and computation validates the use of molecular dynamics simulations as an accurate tool for exploring the molecular motion of T cell receptors and their binding loops.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner

Angela R. Smith, Jesus A. Alonso, Cory M. Ayres, Nishant K. Singh, Lance M. Hellman, Brian M. Baker

Summary: This study shows that modifications at primary anchors, even without structural impact, can significantly affect T cell recognition depending on the TCR. The impact of peptide anchor modification can be sensed by a TCR at regions distant from the modification site, indicating a through-protein mechanism. These findings have implications for the use of anchor-modified peptides and predicting the immunogenicity of tumor neoantigens.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Medicine, Research & Experimental

An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection

Cory A. Brennick, Mariam M. George, Marmar M. Moussa, Adam T. Hagymasi, Sahar Al Seesi, Tatiana V. Shcheglova, Ryan P. Englander, Grant L. J. Keller, Jeremy L. Balsbaugh, Brian M. Baker, Andrea Schietinger, Ion I. Mandoiu, Pramod K. Srivastava

Summary: Through an unbiased approach, a large number of effective anticancer neoepitopes have been identified, with properties distinct from conventional epitopes, offering potential for the development of personalized human cancer vaccines.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Biochemistry & Molecular Biology

Tumor rejection properties of gp100209-specific T cells correlate with T cell receptor binding affinity towards the wild type rather than anchor-modified antigen

Jesus A. Alonso, Angela R. Smith, Brian M. Baker

Summary: T cell functional responses generally correlate with the TCR affinity for a peptide/MHC complex, but outliers exist. In a specific outlier case, the unusual behavior was attributed to the use of a position 2 anchor-modified peptide variant instead of the wild type antigen. This study highlights the importance of considering the differences between modified peptides and wild type antigens when selecting TCRs for immunotherapy.

MOLECULAR IMMUNOLOGY (2021)

Article Cell Biology

HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV

Clarety Kaseke, Ryan J. Park, Nishant K. Singh, Dylan Koundakjian, Arman Bashirova, Wilfredo F. Garcia Beltran, Overbeck C. Takou Mbah, Jiaqi Ma, Fernando Senjobe, Jonathan M. Urbach, Anusha Nathan, Elizabeth J. Rossin, Rhoda Tano-Menka, Ashok Khatri, Alicja Piechocka-Trocha, Michael T. Waring, Michael E. Birnbaum, Brian M. Baker, Mary Carrington, Bruce D. Walker, Gaurav D. Gaiha

Summary: The study found that immunodominant HIV epitopes increase surface stabilization of HLA class-I molecules compared to subdominant epitopes, and HLA class-I-peptide stability is strongly correlated with overall immunodominance hierarchies. Additionally, HLA alleles associated with HIV protection are preferentially stabilized by epitopes derived from topologically important viral regions.

CELL REPORTS (2021)

Article Multidisciplinary Sciences

Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope

Hakimeh Ebrahimi-Nik, Marmar Moussa, Ryan P. Englander, Summit Singhaviranon, Justine Michaux, HuiSong Pak, Hiroko Miyadera, William L. Corwin, Grant L. J. Keller, Adam T. Hagymasi, Tatiana Shcheglova, George Coukos, Brian M. Baker, Ion I. Mandoiu, Michal Bassani-Sternberg, Pramod K. Srivastava

Summary: This study demonstrates that low-affinity MHC I-peptide interactions can also trigger strong T cell response and anti-tumour immunity, despite the canonical concept that high-affinity interactions are essential for immunogenicity. Structural modeling suggests that the increased hydrophobicity of neo-epitope surfaces may contribute to higher TCR reactivity in these non-binding epitopes.

NATURE COMMUNICATIONS (2021)

Review Immunology

Peptide-dependent tuning of major histocompatibility complex motional properties and the consequences for cellular immunity

Cory M. Ayres, Brian M. Baker

Summary: Peptides can impact the dynamic properties of MHC proteins, which in turn have significant implications for the immune system.

CURRENT OPINION IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Engineering the T cell receptor for fun and profit: Uncovering complex biology, interrogating the immune system, and targeting disease

Aaron M. Rosenberg, Brian M. Baker

Summary: This article reviews the history and recent developments in TCR engineering, including efforts to alter TCR affinity, modulate specificity, and develop novel TCR-based constructs.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

A previously unappreciated polymorphism in the beta chain of I-As expressed in autoimmunity-prone SJL mice: Combined impact on antibody, CD4 T cell recognition and MHC class II dimer structural stability

Katherine A. Richards, Courtney Lavery, Grant L. J. Keller, Jim Miller, Brian M. Baker, Andrea J. Sant

Summary: In our study on the MHC class II molecule expressed in autoimmunity prone SJL mice, we identified a variant that alters the structure of the molecule and affects its recognition by certain antibodies. Through monoclonal antibody blocking experiments, we found that CD4 T cells primarily interacted with a specific region of the MHC class II molecule. Our results indicate that conformational variability in this region may lead to a CD4 T cell repertoire that deviates from the prototypical docking mode on MHC class II peptide complexes, while maintaining recognition of the peptide.

MOLECULAR IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

Smita S. Chandran, Jiaqi Ma, Martin G. Klatt, Friederike Dundar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Y. Wen, Britta Weigelt, Paul Zumbo, Si Ning Fu, Lauren B. Banks, Fei Yi, Enric Vercher, Inaki Etxeberria, Watchain D. Bestman, Arnaud Da Cruz Paula, Ilinca S. Aricescu, Alexander Drilon, Doron Betel, David A. Scheinberg, Brian M. Baker, Christopher A. Klebanoff

Summary: Using a high-throughput platform combining single-cell transcriptomic and T cell receptor sequencing, researchers identified an immunogenic public neoantigen derived from mutant PIK3CA. The study further demonstrated that this neoantigen has therapeutic potential and can induce tumor regression when TCR-engineered T cells are adoptively transferred.

NATURE MEDICINE (2022)

Article Immunology

Physicochemical Heuristics for Identifying High Fidelity, Near-Native Structural Models of Peptide/MHC Complexes

Grant L. J. Keller, Laura Weiss, Brian M. Baker

Summary: This study focuses on accurately modeling the structural features of peptides presented by class I MHC proteins. They found that the common strategy of selecting decoys based on lowest energy can lead to significant errors. Instead, they developed a data-driven approach to predict near native decoys with high accuracy.

FRONTIERS IN IMMUNOLOGY (2022)

News Item Biochemistry & Molecular Biology

Chaperoning the dance of antigen presentation

Tatiana J. Rosales, Brian M. Baker

Summary: This research provides new insights into antigen loading onto MHC-I proteins, particularly the 'non-classical' MHC-I protein MR1. It has important implications for fundamental immunology and the development of novel immunotherapies.

NATURE CHEMICAL BIOLOGY (2022)

Article Multidisciplinary Sciences

Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma

Chang Liu, Hong Liu, Moumita Dasgupta, Lance M. Hellman, Xiaogang Zhang, Kai Qu, Hui Xue, Yun Wang, Fenling Fan, Qi Chang, Duo Yu, Linhu Ge, Yu Zhang, Ziyou Cui, Pengbo Zhang, Bradley Heller, Hongbing Zhang, Bingyin Shi, Brian M. Baker, Cheng Liu

Summary: This article describes a novel TCRm-based T cell therapy that shows specificity and safety for hepatocellular carcinoma (HCC). The therapy exhibits potent activity against AFP-positive cancer cell lines in both in vitro and in vivo models without affecting AFP-negative cells. In a human safety assessment, no significant adverse events were observed, and evidence of efficacy was seen. Remarkably, one metastatic HCC patient achieved complete remission after nine months and qualified for a liver transplant.

SCIENTIFIC REPORTS (2022)

Article Multidisciplinary Sciences

A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometry

Nishant K. Singh, Jesus A. Alonso, Jason R. Devlin, Grant L. J. Keller, George Gray, Adarsh K. Chiranjivi, Sara G. Foote, Lauren M. Landau, Alyssa G. Arbuiso, Laura Weiss, Aaron M. Rosenberg, Lance M. Hellman, Michael Nishimura, Brian M. Baker

Summary: The study identified a mismatched TCR with a highly atypical geometry that maintains normal function and specificity, providing insights into the determinants of MHC restriction.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Dynamic allostery controls the peptide sensitivity of the Ly49C natural killer receptor

Jiaqi Ma, Cory M. Ayres, Lance M. Hellman, Jason R. Devlin, Brian M. Baker

Summary: Through biochemical and dynamic allostery analysis, this study reveals that the peptide sensitivity of the inhibitory murine NK receptor Ly49C arises from small differences in H-2K(b)-binding affinity, driven by peptide-dependent dynamic tuning of electrostatic interactions across the protein-protein interface. A proposed model suggests that different peptides can alter the flexibility of H-2K(b), thus changing the strength of electrostatic interactions and providing a quantitative assessment of how peptides impact Ly49C-binding affinity. This research demonstrates peptide-driven allostery at work in class I MHC proteins and provides insight into how dynamic allostery could affect binding of specific MHC partners.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Cell Biology

Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting

Julien Schmidt, Angela R. Smith, Morgane Magnin, Julien Racle, Jason R. Devlin, Sara Bobisse, Julien Cesbron, Victor Bonnet, Santiago J. Carmona, Florian Huber, Giovanni Ciriello, Daniel E. Speiser, Michal Bassani-Sternberg, George Coukos, Brian M. Baker, Alexandre Harari, David Gfeller

Summary: CD8+ T cell recognition of peptide epitopes is crucial in immune responses, but the rules governing which peptides are recognized by T cell receptors remain unclear. Training a predictor called PRIME using recent epitope data improves prediction accuracy, particularly in cancer immunotherapy for identifying new epitopes.

CELL REPORTS MEDICINE (2021)

暂无数据